重组组织型纤维蛋白酶原激活剂治疗白内障手术后的纤维蛋白膜

1. Sterling S.Wood T Effect of intraocular lens convexity on posterior capsule opacification 1986
2. Menapace R.Amon M.Radax U Evaluation of 200 consecutive IOGEL 1103capsular-bag lenses implanted through a small incision 1992
3. Zetterstrom C.Olivestedt G.Lundvall A Exfoliation syndrome and extracapsular cataract extraction with implantation of posterior chamber lens 1992
4. Wedrich A.Menapace R.Radax U.Papapanos P Long-term results of combined trabeculectomy and small incision cataract surgery 1995
5. Goodman DF.Stark W J.Gottsch JD Complications of cataract extraction with intraocular lens implantation 1989
6. Apple DJ.Solomon KD.Tetz MR.Assia EI Holland EY Legler UF Tsai JC Castaneda VE Hoggatt JP Kostick AM Posterior capsule opacification 1992
7. Thorsen S.Glas Greenwalt P.Astrup T Differences in the binding to fibrin of urokinase and tissue plasminogen activator 1972
8. Collen D.Lijnen HR Tissue type plasminogen activator.Mechanism of action and thrombolytic properties 1986(z3)
9. Pennica D.Holmes WE.Kohr WJ.Harkins RN Vehar GA Ward CA Bennett WF Yelverton E Seeburg PH Heyneker HL Goeddel DV Collen D Cloning and expression of human tissue-type plasminogen activator cDNA in E coli 1983
10. Van de Werf F.Bergmann SR.Fox KA.de Geest H Hoyng CF Sobel BE Collen D Coronary thrombolysis with intravenously administered human tissue type plasminogen activator produced by recombinant DNA technology 1984
11. Moon J.Chung S.Myong Y.Chung S Park C Baek N Rhee S Treatment of postcataract fibrinous membranes with tissue plasminogen activator 1992
12. K(o)rnet F.B(o)hnke M Clinical use of recombinant plasminogen activator for intraocular fibrinolysis 1992
13. Wedrich A.Menapace R.Muehlbauer Ries F The use of recombinant tissue plasminogen activator for intracaneral fibrinolysis follwing cataract surgery 1995
14. Heiligenhaus A.Schilling H.Schilling M.Mellin KB Treatment with tissue plasminogen activator (tPA) in risk patients with fibrin reactions after cataract operations 1996
15. Siatiri H.Beheshtnezhad AH.Asghari H.Siatiri N Moghimi S Piri N Intracameral tissue plasminogen activator to prevent severe fibrinous effusion after congenital cataract surgery 2005(11)
16. Erol N.Ozer A.Topbas S.Yildirim N Yurdakul S Treatment of intracameral fibrinous membranes with tissue plasminogen activator 2003(6)
17. Georgiadis N.Boboridis K.Halvatzis N.Ziakas N Moschou V Low-dose tissue plasminogen activator in the management of anterior chamber fibrin formation 2003(4)
18. Heiligenhaus A.Steinmetz B.Lapuente R.Krallmann P Althaus C Steinkamp WK Dick B Recombinant tissue plasminogen activator in cases with fibrin formation after cataract surgery:a prospective randomised multicentre study 1998(7)
19. Sebestyen JG Fibrinoid syndrome:a severe complication of vitrectomy surgery in diabetes 1982
20. Tripathi RC.Park JK.Tripathi B J.Millard CB Tissue plasminogen activator in human aqueous and its possible therapeutic significance 1988
21. Yoshitomi F.Utsumi E.Hayashi M.Futenma M Yamada R Yamada S Postoperative fluctuation of tissue plasminogen activator (t-PA) in aqueous humor of pseudophakes 1991
22. Snyder RW.Lambrou FH.Williams GA Intraocular fibrinolysis with recombinant human tissue plasminogen activator; experimental treatment in a rabbit model 1987
23. Gerding PA Jr.Hamor RE.Ramsey DT.Vasaune S Schaeffer DJ Evaluation of topically administered tissue plasminogen activator for intraocular fibrinolysis in dogs 1994
24. Jaffe G J.Lewis H.Han DP.Williams GA Abrams GW Treatment of postvitrectomy fibrin pupillary block with tissue plasminogen activator 1989
25. Koerner F.Boehnke M Clinical use of recombinant plasminogen activator for intraocular fibrinolysis 1992
26. Laatikainen L.Mattila J The use of tissue plasminogen activator in post-traumatic hyphema 1996
27. Lewis H.Medendorp S Tissue plasminogen activatorassisted surgical excision of subfoveal choroidal neovascularization in age-related macular degeneration 1997
28. Koch DD.Kohnen T Retrospective comparison of techniques to prevent secondary cataract formation after posterior chamber intraocular lens implantation in infants and children 1997
29. Klais CM.Hattenbach LO.Steinkamp GW.Zubcov AA Kohnen T Intraocular recombinant tissue-plasminogen activator fibrinolysis of fibrin formation after cataract surgery in children 1999
30. Miyake K.Asakrura M.Kobayashi H Effect of intraocular lens fixation on the blood-aqueous barrier 1984
31. Fagerholm PP.Philipson BT Experimental traumatic cataract.Ⅱ.A transmission electron microscopy and extracellular tracer study 1979(18)
32. Fagerholm P The response of the lens to trauma 1982
33. Miyake K Blood-retinal barrier in long-standing aphakic eyes after extra-and intracapsular lens extractions 1985
34. Nishi O Fibrinous membrane on the posterior chamber lens during the early postoperative period 1988
35. Krupsky S.Zahlish M.Oliver M.Pollack A Anterior segment complications in diabetic patients following extracapsular cataract extraction and posterior chamber intraocular lens implantation 1991
36. McDermott ML.Edelhauser HF.Hyndiuk RA.Koenig SB Tissue plasminogen activator and the corneal endothelium 1989
37. Johnson MW.Olsen KR.Hernandez E.Irvine WD Johnson RN Retinal toxicity of recombinant tissue plasminogen activator in the rabbit 1990
38. Wedrich A.Menapace R.Ries E.Polzer I Intracameral tissue plasminogen activator to treat severe fibrinous effusion after cataract surgery 1997
39. Wollensak G.Meyer JH.Loffler KU.Funk J Band-like keratopathy alter treatment of postoperative fibrin reaction with tissue plasminogen activator 1996
40. Rehfeldt K.Hoh H Therapeutic and prophylactic application of TPA (recombinant tissue plasminogen activator) into the anterior chamber of the eye 1999

更多...